CLINICAL TRIALS PROFILE FOR EDETATE CALCIUM DISODIUM
✉ Email this page to a colleague
All Clinical Trials for EDETATE CALCIUM DISODIUM
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00378781 ↗ | Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection | Withdrawn | National Cancer Institute (NCI) | N/A | 1969-12-31 | RATIONALE: Heparin or M-EDTA may prevent catheter-related infections and blockages in patients at high risk for a catheter-related infection. It is not yet known whether heparin is more effective than M-EDTA in preventing catheter-related infections and blockages in patients at high risk for a catheter-related infection. PURPOSE: This randomized clinical trial is studying heparin to see how well it works compared with M-EDTA in preventing catheter-related infections and blockages in patients at high risk for a catheter-related infection. |
| NCT00378781 ↗ | Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection | Withdrawn | M.D. Anderson Cancer Center | N/A | 1969-12-31 | RATIONALE: Heparin or M-EDTA may prevent catheter-related infections and blockages in patients at high risk for a catheter-related infection. It is not yet known whether heparin is more effective than M-EDTA in preventing catheter-related infections and blockages in patients at high risk for a catheter-related infection. PURPOSE: This randomized clinical trial is studying heparin to see how well it works compared with M-EDTA in preventing catheter-related infections and blockages in patients at high risk for a catheter-related infection. |
| NCT01101412 ↗ | Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies | Withdrawn | National Cancer Institute (NCI) | Phase 1/Phase 2 | 1969-12-31 | RATIONALE: Antimicrobial solution comprising trimethoprim-sulfamethoxazole, edetate calcium disodium, and ethanol may help prevent blockages and infections from forming in patients with central venous access catheters or peripheral venous catheters. PURPOSE: This randomized trial is studying an antimicrobial solution or saline solution in maintaining catheter patency and preventing catheter-related blood infections in patients with malignancies. |
| NCT01101412 ↗ | Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies | Withdrawn | M.D. Anderson Cancer Center | Phase 1/Phase 2 | 1969-12-31 | RATIONALE: Antimicrobial solution comprising trimethoprim-sulfamethoxazole, edetate calcium disodium, and ethanol may help prevent blockages and infections from forming in patients with central venous access catheters or peripheral venous catheters. PURPOSE: This randomized trial is studying an antimicrobial solution or saline solution in maintaining catheter patency and preventing catheter-related blood infections in patients with malignancies. |
| NCT02421029 ↗ | Prolonged Gadolinium Retention After MRI Imaging | Withdrawn | Mt. Sinai Medical Center, Miami | Phase 4 | 2017-07-01 | The researchers propose to investigate the prevalence of gadolinium in the urine of patients with a prior gadolinium-enhanced MRI before and after a edetate calcium disodium challenge. Moreover, will investigate if there is any correlation of gadolinium urine levels with levels of endogenous (e.g zinc) and xenobiotic metals. |
| NCT03630991 ↗ | Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy | Recruiting | National Cancer Institute (NCI) | Phase 1 | 2018-10-11 | This phase I trial studies the side effects and best dose of edetate calcium disodium or succimer in treating patients with acute myeloid leukemia or myelodysplastic syndrome undergoing chemotherapy. Edetate calcium disodium or succimer may help to lower the level of metals found in the bone marrow and blood and may help to control the disease and/or improve response to chemotherapy. |
| NCT03630991 ↗ | Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy | Recruiting | M.D. Anderson Cancer Center | Phase 1 | 2018-10-11 | This phase I trial studies the side effects and best dose of edetate calcium disodium or succimer in treating patients with acute myeloid leukemia or myelodysplastic syndrome undergoing chemotherapy. Edetate calcium disodium or succimer may help to lower the level of metals found in the bone marrow and blood and may help to control the disease and/or improve response to chemotherapy. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for EDETATE CALCIUM DISODIUM
Condition Name
| Condition Name for EDETATE CALCIUM DISODIUM | |
| Intervention | Trials |
| Myelodysplastic Syndromes | 1 |
| Secondary Acute Myeloid Leukemia | 1 |
| Chronic Myelomonocytic Leukemia | 1 |
| Myelodysplastic/Myeloproliferative Neoplasm | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for EDETATE CALCIUM DISODIUM
Trials by Country
Clinical Trial Progress for EDETATE CALCIUM DISODIUM
Clinical Trial Phase
Clinical Trial Sponsors for EDETATE CALCIUM DISODIUM
Sponsor Name
